North America to Hold Pole Position in Quick Relief Asthma Treatment Market Finds Fact.MR

Retail pharmacies will drive the highest sales of asthma therapeutics with an estimated value of around US$ 17 Bn by 2027, as rapid expansion of retail pharmacies makes asthma therapeutics more accessible to patients. According to a recent Fact.MR study, hospital pharmacies with large drug inventories would also remain a crucial distribution channel in the asthma treatment market. As patients find it convenient to purchase drugs immediately after diagnosis, hospital pharmacies are likely to catalyse sales of asthma therapeutics during the forecast period (2020-2027). The study finds that, hospital pharmacies hold the potential to drive sales tantamount to US$ 10 Bn by 2027, in the asthma treatment market.

Click Here to Get complete Synopsis of this Report https://www.factmr.com/report/4422/asthma-treatment-market

Key Highlights of Asthma Treatment Market Study

Sales of long-term asthma control medications would remain 59% higher as compared to quick-relief medications by 2027, as rescue medications have limited application scope (only used during asthma attacks), while long-term medications possess high efficacy to control asthma attacks.

Loss of patent exclusivity of branded drugs could affect the position of leading players in the asthma treatment market, as generic drugs gain ground. For instance, patents of Symbicort Turbuhaler and Qvar manufactured by AstraZeneca and GlaxoSmithKline PLC respectively, are to expire in the very near future. High availability of generic drugs to treat mild to severe asthma is projected to adversely affect revenue potential of the asthma treatment market during the forecast period.

Sales of inhalers are projected to cross US$ 14 Bn by 2027, and oral route of administration is likely to grow as the second-most attractive section in the asthma treatment market.

Relaxed FDI policies in India and China are projected to shift focus of leading players towards Asia Pacific to achieve reduced overhead costs and meet growing demand for asthma therapeutics in these countries. According to the Lung India Journal, India accounts for one in every 10 asthma patients. On the back of increasing demand for asthma therapeutics and improving supply chain, the Asia Pacific asthma treatment market is projected to witness growth in the market.
For More Insights Into The Market, Request a Sample of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=4422

Global Asthma Treatment Market: Segmentation

Treatment Type

Long-term Asthma Control Medications
Combination Inhalers
Inhaled Corticosteroids
Long-acting Beta Agonists
Leukotriene Modifiers
Theophylline
Others (reslizumab, benralizumab, etc.)
Quick-relief (Rescue) Medications

Short-acting Beta Agonists
Oral & Intravenous Corticosteroids

Following Questions Answers Covered in the Report are:

How will the global Asthma Treatment Market perform during the forecast period? What will be the market size in terms of value and volume?
Which segment will drive the global Asthma Treatment Market? Which regional market will show extensive growth in the future? What are the reasons?
How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
What are the key strategies adopted by players to sustain themselves in the global Asthma Treatment Market?
How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts - https://www.factmr.com/connectus/sample?flag=RM&rep_id=4422

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights -http://www.globenewswire.com/en/news-release/2019/02/27/1743494/0/en/Background-Music-Becoming-a-Must-Have-as-Cafes-Restaurants-Look-to-Engage-Millennials-finds-Fact-MR-Study.html

The Report Covers Exhaustive Analysis On:

Market Segments
Market Dynamics
Market Size & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Share Your Requirements & Get Customized Reports - https://www.factmr.com/connectus/sample?flag=RC&rep_id=4422

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.